Tag: Prevail Therapeutics
Sangamo, Prevail Therapeutics ink deal for evaluating AAV capsids
Sangamo Therapeutics, a genomic medicine company, has entered an evaluation and option agreement with Prevail Therapeutics, an Eli Lilly subsidiary, for novel engineered capsids. The ... Read More
Lilly to acquire gene therapy firm Akouos to discover hearing loss treatments
Lilly acquisition of Akouos : American pharmaceutical giant Eli Lilly and Company (Lilly) has agreed to acquire precision genetic medicine company Akouos in a cash ... Read More
Lilly to open $700m Lilly Institute for Genetic Medicine in Boston
Eli Lilly and Company (Lilly) has revealed plans to open a new research facility for genetic medicine dubbed as Lilly Institute for Genetic Medicine in ... Read More
Lilly wraps up acquisition of gene therapy company Prevail Therapeutics
Eli Lilly and Company (Lilly) has completed its previously announced deal worth up to $1.04 billion of US gene therapy company Prevail Therapeutics. The US ... Read More
Lilly to acquire US gene therapy company Prevail Therapeutics in $1bn deal
Eli Lilly and Company (Lilly) has signed a deal worth up to $1.04 billion to acquire Prevail Therapeutics, a US gene therapy company engaged in ... Read More